FOXO unit to acquire four U.S. blood collection centers from Grifols subsidiary — See source for full details.
$GRFS
Price history, market instrument context, member research, and related headlines in one place.
GRFS key statistics
NasdaqGSUSD
52-week range
$6.9620%$9.90
Latest session $7.49–$7.57Grifols, S.A. (GRFS) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $7.56, up $0.11 (1.48%) from the previous close of $7.45. It has traded between $7.49 and $7.57 in the latest session. Over the past year it has ranged from $6.96 to $9.90, leaving it in the lower quarter of its 52-week range (20%). Reported volume for the session was 992.3K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
WOOK AIASK ANYTHING · NEVER ADVISES
Meet Wook AI, your friendly assistant. Ask how something works, about any company, fund or coin, or have it do the math — live figures come from this site’s own lookups, and you’ll see which ones it used.
Source-linked intelligence
Related news
Grifols H1 2026 slides: cash flow surges as IG drives growth — See source for full details.
Earnings call transcript: Grifols holds guidance as H1 2026 cash flow improves — See source for full details.
Loading $GRFS research…